Phosphates and Lactate (FSKP) Flashcards

0
Q

% phosphate in bone, in soft tissues and in serum/plasma (active form)

A

80% in bone, 20% in soft tissues, <1% in serum/plasma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

Predominant intracellular anion

A

Phosphate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Concentration of phosphate in blood

A

12 mg/dL (3.9 mmol/L)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Concentration of inorganic phosphates in blood

A

3-4 mg/dL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

complex phosphodiesters

A

DNA and RNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Coenzymes of phosphates

A

Esters of phosphoric or pyrophosphoric acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Reservoirs of energy (phosphate)

A

ATP, creatine phosphate and phosphoenolpyruvate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Facilitates release of O2

A

2,3-biphosphoglycerate (2,3-BPG) in RBcs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

-Acts to increase Phosphate in the blood

A

Vitamin D (increased)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

-Increases both phosphate absorption in the intestine and phosphate reabsorption in the kidney

A

Vitamin D (increased)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

In excessive secretion or administration of this, phosphate in the blood may increase because of decreased renal excretion

A

Growth hormone (increased)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Decreases phosphate by inhibiting reabsorption

A

PTH and calcitonin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

60-80% of patients in ICU with hypophosphatemia has

A

Sepsis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Causes of hypophosphatemia

A
  • increased renal excretion
  • hyperparathyroidism
  • decreased intestinal absorption, as w/ vit. D deficiency or antacid use
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Mortality rate of mild hypophosphatemia

A

15%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Mortality rate of severe hypophosphatemia

A

<1.0 g/dL or 0.3 mmol/L

30%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Causes of hyperphosphatemia

A
  • increased intake of phosphate (neonates)
  • increased breakdown of cells
  • lymphoblastic leukemia
17
Q

Specimen for determination of inorganic phosphate

A

Serum or Li heparin plasma, urine (24hr)

18
Q

Sources of error of inorganic phosphate

A
  • oxalate, citrate, or EDTA: interfere
  • hemolysis: high conc. inside RBCs
  • Circadian rhythm: highest in late morning and lowest in the evening
19
Q

Methods (phosphate)

A

Colorimetry

1. Fiske Subbarow
2. Gomori Modification
20
Q

Formation of an ammonium phosphomolybdate complex (colorless)

A

Colorimetry

21
Q

Colorimetry is read by

A

UV absorption at 340 nm or reduced to form molybdenum blue read at 500-700 nm

22
Q

Specimen of this method is precipitated with TCA

A

Fiske Subbarow

23
Q

This method uses Molybdenum reagent to form heteromolybdenum complex or phosphomolybdate complex

A

Gomori Modification

24
Q

Reference range of serum/plasma for phosphate in neonates

A

1.45-2.91 mmol/L (4.5-9.0 mg/dL)

25
Q

Reference range of serum/plasma for phosphate in child

A

1.45-1.78 mmol/L (4.5-5.5 mg/dL)

26
Q

Reference range of serum/plasma for phosphate in adults

A

0.87-1.45 mmol/L (2.7-4.5 mg/dL)

27
Q

Reference range of 24 hr urine for phosphate

A

13-42 mmol/day (0.4-1.3 g/day)

28
Q

By-product of an emergency mechanism producing a small amount of ATP when O2 delivery is severely diminished

A

Lactate

29
Q

The normal end product of glucose metabolism (glycolysis)

A

Pyruvate

30
Q

Conversion of pyruvate to lactate is activated when

A

A deficiency of oxygen leads to an accumulation of excess NADH

31
Q

Associated with hypoxic conditions (shock, myocardial infarction, severe blood loss)

A

Type A lactic acidosis

32
Q

Metabolic origin (diabetes mellitus, severe infection, leukemia, liver or renal disease, and toxins [ethanol, methanol, salicylate poisoning])

A

Type B lactic acidosis

33
Q

Specimen for determination of lactate

A
  • tourniquet should not be used: venous stasis will increase lactate levels
  • do not exercise the hand
  • anaerobic glycolysis should be prevented
  • heparinized blood may be used: must be delivered on ice and plasma must be quickly separated
  • use iodoacetate or fluoride to inhibit glycolysis w/o affecting coag
34
Q

Methods (lactate)

A
Monitoring oxygenation
Enzymatic method (coupled)
35
Q

Enzymatic method (coupled)

A

Lactae + oxygen (acted by the enzyme: lactate oxidase)—-> pyruvate + hydrogen peroxide (H2O2)

Hydogen peroxide + H donor + chromogen (acted by the enzyme: peroxidase) —-> colored dye + 2 water (H2O)

36
Q

Reference Range of lactate (venous)

A

0.5-2.2 mmol/L (4.5-19.8 mg/dL)

37
Q

Reference range of lactate (arterial)

A

0.5-1.6 mmol/L (4.5-14.4 mg/dL)

38
Q

Reference range of lactate (CSF)

A

1.1-2.4 mmol/L (10-22 mg/dL)

39
Q

Monitoring oxygenation

A
  • in dwelling catethers that measure blood flow
  • pulse oximeters
  • base-excess determination
  • measurements of oxygen consumption (VO2)